A recent study developed a clinical-grade lentiviral gene therapy vector for Diamond–Blackfan anemia (DBA) that uses an engineered human GATA1 enhancer (hG1E) to drive regulated expression of the transcription factor GATA1 [195]. This evidence concerns the gene GATA1 and Diamond-Blackfan anemia.